Exothermic R&D Squeeze
Today’s Change (Mar 17, 2026)
—
A symphony is an automated trading strategy — Learn more about symphonies here
About
A rule-based, momentum-driven equity strategy focused on innovative tech and biotech. It uses short-term signals from BE, QS, and IONQ to pick a top asset from related groups, then weights positions by inverse volatility (risk-aware sizing) with a cash cushion. It aims for selective exposure to high-R&D themes while limiting turnover.
- Start with cash as a baseline and apply an equal-cash look. Then size positions using inverse volatility, so steadier assets get bigger weights and more volatile ones get smaller weights.
- Three momentum-trigger branches decide what universe to consider next:
1) If Bloom Energy (BE) has a strong one-day move, evaluate BE and a real-estate/REIT/related asset group. From that group, pick the single top performer over the last ~12 trading days and tilt toward it, with weights adjusted inversely by its volatility.
2) If QuantumScape (QS) has a strong one-day move, look at a pool of international tech and semiconductor-related assets (examples include EWY, EWT, SMH, XLK, XLI, TSM, KORU). Select the top two by 12-day cumulative return and weight them inversely to their volatility.
3) If IonQ (IONQ) has a strong one-day move, focus on biotech-related assets (IBB, XBI, LABU, ARKG, ALNY, CRSP, BEAM, JNJ, BSX). Pick the top one by 12-day cumulative return and weight it inversely to volatility.
- If a trigger is not satisfied, each branch has its own fallback pool and selection rule, always defaulting to a top-performing asset by the same 12-day lookback, but maintaining inverse-vol weighting and cash-equal allocations where shown in the logic.
- The lookbacks are short (1-day for the trigger, 12-day for ranking), and the system uses a narrow set of asset groups to keep turnover modest while aiming to ride momentum in high-disruption sectors.
- The overall exposure class is equities, with a tiny “rebalance corridor” (0.25%) that limits drift and a note that the explicit “rebalance” action is conditional (none by default).
- In plain terms: the model looks for signs of momentum in three big, innovative themes (BE for clean-energy-ish tech, QS for solid-state/EV tech, and IonQ for quantum/AI hardware), then picks a top-performing related asset from that theme and sizes the position to be more stable if possible, while keeping some cash and avoiding overtrading.
Satellite strategy focused on disruptive tech/biotech (BE/QS/IONQ) with inverse-volatility sizing and a cash cushion. Out-of-sample returns trail the S&P (−7.1% vs +6.4%), but adds diversification, lower beta, and potential upside when innovation momentum returns.
1M
3M
6M
YTD
1Y
3Y
Max
Performance
Compared to selected benchmarks
| Alpha | Beta | R2 | R | |
|---|---|---|---|---|
| 0.33 | 1.2 | 0.23 | 0.48 |
Performance Metrics
| Cumulative Return | Annualized Return | Trailing 1M Return | Trailing 3M Return | Sharpe Ratio | |
|---|---|---|---|---|---|
| 62.86% | 23.03% | -2.02% | -1.16% | 1.4 | |
| 235.58% | 67.28% | 1.65% | 14.19% | 1.52 |
Initial Investment
$10,000.00
Final Value
$33,558.20Regulatory Fees
$217.74
Total Slippage
$1,235.38
Invest in this strategy
OOS Start Date
Jan 13, 2026
Trading Setting
Threshold 0.25%
Type
Stocks
Category
Growth/innovation strategy, rule-based, momentum, inverse-volatility, sector-specific
Tickers in this symphonyThis symphony trades 26 assets in total
Ticker
Type
ALNY
Alnylam Pharmaceuticals, Inc.
Stocks
ARKG
ARK Genomic Revolution ETF
Stocks
BALI
iShares U.S. Large Cap Premium Income Active ETF
Stocks
BE
Bloom Energy Corporation
Stocks
BEAM
Beam Therapeutics Inc. Common Stock
Stocks
BSX
Boston Scientific Corp.
Stocks
CRSP
CRISPR Therapeutics AG
Stocks
ERY
Direxion Daily Energy Bear 2X ETF
Stocks
EWT
iShares MSCI Taiwan ETF
Stocks
EWY
iShares MSCI South Korea ETF
Stocks